72 POSTER Preclinical evaluation of the tyrosine kinase inhibitor erlotinib: Bioanalytical method development and pharmacokinetic analysis and in vivo evaluation and comparison in a panel of human EGFR wildtype and mutant tumor xenograft models
F.E. Nieves, J. Cooper, G.L. Mangold, J. Kuhn, C.H. Takimoto, A.W. Tolcher, M.J. WickVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72004-4
File:
PDF, 59 KB
english, 2008